Hall Steven Edward
Insider CIK 1602732 · PTGX 10% owner · CERU Director, 10% owner · ALRN · FMTX Director · SURF 10% owner · KYMR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,063 | — | $0 | 20,063 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 2,511,198 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 985,220 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion | 2020-08-25 | 2020-08-25 | 2,192,249 | — | $0 | 2,192,249 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-08-20 | 2020-08-21 | 40,127 | — | $0 | 40,127 | SEC↗ |
| FMTX Forma Therapeutics Holding | C Conversion deriv | 2020-06-23 | 2020-11-25 | 5,833,333 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | C Conversion deriv | 2020-06-23 | 2020-11-25 | 3,178,630 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | C Conversion | 2020-06-23 | 2020-11-25 | 2,106,828 | — | $0 | 2,404,069 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion deriv | 2018-04-23 | 2018-04-23 | 7,000,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | P Buy | 2018-04-23 | 2018-04-23 | 266,000 | $15.00 | $3.99M | 3,447,817 | SEC↗ |
| SURF Surface Oncology, Inc. | C Conversion | 2018-04-23 | 2018-04-23 | 3,181,817 | — | $0 | 3,181,817 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 1,654,411 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 1,443,972 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 1,907,373 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-07 | 3,390,885 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2017-07-05 | 2017-07-07 | 250,000 | $15.00 | $3.75M | 1,094,987 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion | 2017-07-05 | 2017-07-07 | 844,987 | — | $0 | 844,987 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-16 | 3,000,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-16 | 9,142,857 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion deriv | 2016-08-16 | 2016-08-16 | 9,841,333 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-16 | 630,541 | — | $0 | 837,437 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-16 | 206,896 | — | $0 | 206,896 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2016-08-16 | 2016-08-16 | 583,333 | $12.00 | $7.00M | 2,099,482 | SEC↗ |
| PTGX Protagonist Therapeutics, | C Conversion | 2016-08-16 | 2016-08-16 | 678,712 | — | $0 | 1,516,149 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-06-26 | 2015-06-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 4,340,831 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 13,513,513 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | P Buy | 2014-04-15 | 2014-04-15 | 733,445 | $7.00 | $5.13M | 2,356,227 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 199,875 | — | $0 | 1,622,782 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 931,485 | — | $0 | 931,485 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 192,209 | — | $0 | 1,422,907 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 299,213 | — | $0 | 1,230,698 | SEC↗ |